Elevai Labs Valuation

Is ELAB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ELAB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ELAB's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ELAB's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ELAB?

Key metric: As ELAB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ELAB. This is calculated by dividing ELAB's market cap by their current revenue.
What is ELAB's PS Ratio?
PS Ratio	2.2x
Sales	US$2.45m
Market Cap	US$5.31m

ELAB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does ELAB's PS Ratio compare to its peers?

The above table shows the PS ratio for ELAB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.9x
UPXI Upexi	0.06x	n/a	US$5.0m
SISI Shineco	0.4x	n/a	US$4.3m
HYEX Healthy Extracts	2.3x	n/a	US$7.1m
AXIL AXIL Brands	1x	n/a	US$27.4m
ELAB Elevai Labs	2.2x	n/a	US$5.3m

Price-To-Sales vs Peers: ELAB is expensive based on its Price-To-Sales Ratio (2.2x) compared to the peer average (0.9x).

Price to Sales Ratio vs Industry

How does ELAB's PS Ratio compare vs other companies in the US Personal Products Industry?

26 Companies	Price / Sales	Estimated Growth	Market Cap
HLF Herbalife	0.2x	1.8%	US$783.15m
NUS Nu Skin Enterprises	0.2x	-0.06%	US$362.89m
MED Medifast	0.3x	-13.4%	US$209.52m
SKIN Beauty Health	0.5x	5.7%	US$183.70m

26 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: ELAB is expensive based on its Price-To-Sales Ratio (2.2x) compared to the US Personal Products industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is ELAB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ELAB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate ELAB's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.